Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Day: April 24, 2025

Rare Disease news

Rare Diseases Weekly News - April 24th 2025

This Week in Rare Disease Breakthroughs 🧬 | Gene Therapies, Drug Approvals…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - April 24th 2025

🔬 This Week in Gene & Cell Therapy: Key Breakthroughs in Lupus,…

Cardiovascular

Cardiovascular Weekly News - April 24th 2025

❤️ Breaking Cardiovascular News: AI, Diagnostics & Life-Saving Therapies!……

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Vaccines Today—April 3, 2026
Public Health Today—April 3, 2026
Lucid Diligence Brief: Eli Lilly acquires Centessa Pharmaceuticals
Lucid Diligence Brief: CellCarta and Pillar Biosciences strategic partnership
Cardiovascular Today—April 2, 2026

Tags

Alzheimer’s psychosis anti-aging Avenzo Therapeutics Bofanglutide breast cancer genomics cancer care cancer vaccines China NMPA Chronic myeloid leukemia chronic rhinosinusitis with nasal polyps competitive advantage CORD cryo-EM Daewoong Pharmaceutical Fertility issues Gastroenterology exit strategy Gene and cell therapy in hematology gestational trophoblastic tumors GLP-1 combinations Health Systems Transformation HeartFlow Hematopoietic Stem Cells homozygous familial hypercholesterolemia Intracranial atherosclerosis Li Fraumeni syndrome Merck & Co. Non-muscle invasive bladder cancer olid Biosciences oral therapies Oxford Pain PBS Australia pharma R&D Phenylketonuria plasma-derived therapies Recor Medical RIPTAC platform sexual health target discovery Tecvayli Tether QVAC Health Theramex Thrombotic thrombocytopenic purpura vre infection Zealand Pharma

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Vaccines Today—April 3, 2026
Public Health Today—April 3, 2026
Lucid Diligence Brief: Eli Lilly acquires Centessa Pharmaceuticals
Lucid Diligence Brief: CellCarta and Pillar Biosciences strategic partnership
Cardiovascular Today—April 2, 2026

TAGS

Alzheimer’s psychosis anti-aging Avenzo Therapeutics Bofanglutide breast cancer genomics cancer care cancer vaccines China NMPA Chronic myeloid leukemia chronic rhinosinusitis with nasal polyps competitive advantage CORD cryo-EM Daewoong Pharmaceutical Fertility issues Gastroenterology exit strategy Gene and cell therapy in hematology gestational trophoblastic tumors GLP-1 combinations Health Systems Transformation HeartFlow Hematopoietic Stem Cells homozygous familial hypercholesterolemia Intracranial atherosclerosis Li Fraumeni syndrome Merck & Co. Non-muscle invasive bladder cancer olid Biosciences oral therapies Oxford Pain PBS Australia pharma R&D Phenylketonuria plasma-derived therapies Recor Medical RIPTAC platform sexual health target discovery Tecvayli Tether QVAC Health Theramex Thrombotic thrombocytopenic purpura vre infection Zealand Pharma

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy